Question

Which of the following does not count as a contraindication for performing a transcystic laparoscopic common bile duct (CBD) exploration?

• A. 5–8 mm stones
• B. $>$ 8 stones
• C. Unable to dilate cystic duct
• D. Intrahepatic stone

Hint:

Transcystic vs. Choledochotomy CBD Exploration:
- Transcystic: Good for small ($<8$mm), few ($<4$), distal stones.
- Choledochotomy: Required for large stones ($>10$mm), many stones, proximal/intrahepatic stones, or dilated CBD ($>15$mm).

Answer 1

The Correct Option is A

Concept:
Laparoscopic CBD exploration can be performed via a transcystic route (through the cystic duct) or a choledochotomy (direct incision into the CBD). The choice depends on stone characteristics and ductal anatomy.
Explanation:
• The transcystic approach is generally the preferred, less morbid first-line method for clearing the CBD during a laparoscopic cholecystectomy.

• It is ideal for small stones (typically $<$ 6-8 mm), a small number of stones (e.g., $<$ 4), and stones located distally (below the cystic duct junction). Thus, 5-8 mm stones (Option A) are the perfect indication for a transcystic approach, not a contraindication.

• Conversely, situations where the transcystic route will likely fail or cause injury are contraindications, necessitating a direct choledochotomy instead.

• Contraindications to transcystic exploration include:
- A high number of stones (e.g., $>$ 8 stones, Option B).
- A small, friable, or tortuous cystic duct that cannot be safely dilated to accommodate the choledochoscope (Option C).
- Stones located proximally, above the cystic duct-CBD junction, such as intrahepatic stones (Option D), because the choledochoscope cannot easily be steered backwards up into the hepatic ducts from the cystic duct angle.
- Large stones ($>$ 8-10 mm) that exceed the maximum dilatable diameter of the cystic duct.
Final Answer:
Stones measuring 5-8 mm are well within the size limit for transcystic retrieval and thus do not constitute a contraindication for the procedure.